Europe Dermal Filler Market share was valued at over USD 1.4 billion in 2019 and is expected to witness over 7.3% CAGR from 2020 to 2026.
Dermal fillers are used to improve recessed scar appearance, plump thin lips and enhance shallow contours. They are widely used in treatment of facial smile lines and wrinkles. These are gel-like substances injected beneath the skin to recover lost volume and are being rapidly adopted since recent years.
Get more details on this report - Request Free Sample PDF
Dermal fillers have witnessed surge in demand with increasing awareness among population and its availability. The knowledge about cosmetic procedures has also driven preference for minimally invasive treatments. In the region, more than 20% of population was aged 65 years and above in 2019. Thus, growing geriatric population leads to increase in procedural volume for wrinkles and line treatments. In addition, incidence of severe burns and accidents drives the number of minimally invasive dermal procedures to minimize the pain and enhance dermal healing. Therefore, considering overall geriatric population, focus on aesthetics and severe injuries, the market will foresee tremendous demand for dermal fillers over the forecast timeframe.
Europe Market, By Type
Based on type, dermal filler market is segmented as biodegradable and non-biodegradable. Further, biodegradable is classified as temporary and semi-permanent. Non-biodegradable dermal filler segment is projected to progress at 8.6% CAGR during the analysis period. The longevity of these dermal fillers influences the product sales. Moreover, biocompatibility of these materials including polymethylmethacrylate beads further stimulates its adoption rate. Thus, owing to its benefits offering continuous support to skin for longer period, the segment will foresee significant demand in coming years.
Europe Market, By Material Type
Dermal filler market on the basis of material type is segmented as hyaluronic acid (HA), calcium hydroxylapatite (CaHA), Poly-L-lactic acid, Polymethyl-methacrylate microspheres (PMMA), fat and others. Calcium hydroxylapatite segment held over USD 80 million revenue in 2019. Calcium hydroxylapatite enhances the surface texture by stimulating collagen, thus increasing its longevity. Moreover, it is natural substance increasingly used for deeper lines and wrinkle treatment. Due to the thicker consistency it offers long-term sustainability. Therefore, aforementioned factors will provide immense growth opportunities to the segment over forecast period.
Europe Market, By Application
Based on application, dermal filler market is segmented as facial line correction, face lift, lip enhancement and others. Lip enhancement segment is set to witness more than 8.0% CAGR during the forecast timeframe. Growing demand for lip fillers due to the increasing focus on facial aesthetics will benefit the segmental growth. Lip injectables help regain lost lip volume and improve overall appeal. Also, growing popularity of such procedures increase its preference among the female population. Thus, advantages such as gradual pace of treatment, less bruising, easily dissolved bumps and reasonably lasting results will positively impact the segment growth.
Europe Market, By End-user
On the basis of end-users, dermal filler market is segmented as dermatological clinics, hospitals and others. Hospitals accounted for more than USD 100 million revenue size in 2019. Hospitals have sophisticated infrastructure with highly skilled plastic surgeons and technologically advanced instruments. The facility preference is contributable to quality services provided for aesthetic treatment. Additionally, considerable spending on cosmetic procedures by customers with infrastructure development will highly impact segment market growth in the future.
Europe Market, By Country
Germany dermal filler market held over USD 200 million market share in 2019 and is anticipated to progress at momentous rate over analysis period. Growing geriatric population and awareness about variety of facial aesthetic treatment will propel regional revenue growth. In addition, continuously increasing innovations and adoption of developed technologies by dermatologist will further impel the demand for dermal fillers in the country in the forecast years.
Competitive Market Share
Few of the established industry players involved in Europe dermal filler market include Allergan Plc, Merz Pharma GmbH & Co. KGaA, Galderma and Sinclair Pharma among others. Market players are undertaking various strategies such as collaborations and product introduction to enhance their market foothold. For instance, in November 2018, Galderma announced U.S. FDA approval for its product Restylane Lyft, a hyaluronic acid (HA) dermal filler intended for correction of age-related midface contour deficiencies and cheek augmentation that broadened company’s product portfolio.
During late 1800s, after invention of injectable syringes, chemical agents were used in facial augmentation. Very first paraffin injectable was abandoned due to some complications such as migration and embolization. In 1970s, animal collagens that were tested for use in humans resulted into development of collagen injectables and implants. Further, the introduction of hyaluronic acid (HA) dermal fillers offered efficient option for permanent fillers. Later, next generation HA family was approved by FDA in 2006. With research and development on various aspects, substantial number of dermal fillers were approved with enhanced biocompatibility, affordability and longevity. Hence, continuous development in dermal fillers will continue to create opportunities for the industry growth.